|
|
|
Insider
Information: |
Posard Matthew L. |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
386,328 |
|
Indirect Shares
|
100,000 |
|
|
Direct
Value |
$9,040,533 |
|
|
Indirect Value
|
$269,000 |
|
|
Total
Shares |
486,328 |
|
|
Total
Value |
$9,309,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-78.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Illumina Inc |
ILMN |
Sr VP & General Manager |
2013-05-30 |
30,858 |
|
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
119,755 |
2013-03-27 |
0 |
Premium* |
|
Cardiff Oncology Inc |
CRDF |
Officer |
2015-08-21 |
15,000 |
|
0 |
Premium* |
|
Dermtech Ord Shs |
DMTK |
Director |
2023-06-01 |
158,215 |
|
0 |
Premium* |
|
Talis Biomedical Corp |
TLIS |
Director |
2021-02-17 |
62,500 |
2021-02-17 |
0 |
Premium* |
|
Nautilus Biotechnology, Inc |
NAUT |
Director |
|
0 |
2021-06-09 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
Sr VP & GM, Consumer Genomics |
|
2012-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,292 |
29,099 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2012-08-01 |
5 |
A |
$35.62 |
$926 |
D/D |
26 |
29,125 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-01-27 |
4 |
D |
$51.62 |
$34,172 |
D/D |
(662) |
28,437 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-01-28 |
4 |
D |
$51.62 |
$37,579 |
D/D |
(728) |
27,709 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,458 |
32,167 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-01-31 |
4 |
D |
$50.63 |
$15,189 |
D/D |
(300) |
31,867 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-03-08 |
4 |
D |
$53.77 |
$87,322 |
D/D |
(1,624) |
30,858 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-04-11 |
4 |
AS |
$57.95 |
$2,795,044 |
D/D |
(48,232) |
30,858 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-04-11 |
4 |
OE |
$20.04 |
$1,468,583 |
D/D |
48,232 |
42,408 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-05-30 |
4 |
AS |
$70.80 |
$200,789 |
D/D |
(2,836) |
30,858 |
0 |
- |
|
ILMN |
Illumina Inc |
Sr VP & General Manager |
|
2013-05-30 |
4 |
OE |
$37.04 |
$105,045 |
D/D |
2,836 |
33,694 |
0 |
- |
|
NAUT |
Nautilus Biotechnology, I... |
Director |
|
2021-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
100,000 |
|
% |
|
TLIS |
Talis Biomedical Corp |
Director |
|
2021-02-17 |
4 |
B |
$16.00 |
$1,000,000 |
D/D |
62,500 |
62,500 |
2.39 |
- |
|
38 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|